Monitor whether the activist group continues to trim its position in subsequent filings, as this sale may signal reduced conviction or profit-taking. Watch for any changes in the stated purpose in future amendments.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $7.86entry
- T+1 · 4d ago +4.45%α +4.82% · $8.21
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Amendment No. 2 to Schedule 13D filed by Dr. Yair C. Schindel and affiliated entities (aMoon Growth Fund, aMoon Edge, etc.) discloses that on November 10, 2026, aMoon Edge sold 192,541 Ordinary Shares of SOPHiA GENETICS SA in a private block sale at $7.70 per share, for gross proceeds of approximately $1.48 million. After the sale, aMoon Growth holds 5,318,023 Ordinary Shares, representing approximately 6.2% of the outstanding shares. The filing amends Items 4 and 5, indicating a slight reduction in the activist group's stake.
Key Financial Metrics
Key Facts
- On November 10, 2026, aMoon Edge sold 192,541 Ordinary Shares in a private block sale at $7.70 per share, gross proceeds approximately $1.48 million.
- After the sale, aMoon Growth holds 5,318,023 Ordinary Shares, approximately 6.2% of outstanding shares (based on 85,658,321 shares outstanding as of September 30, 2026).
- The filing amends Items 4 and 5 of the Schedule 13D, originally filed January 9, 2023, and amended May 18, 2023.
- The Reporting Persons include Schindel, aMoon Growth, aMoon Growth G.P., aMoon Ltd., aMoon Edge, aMoon Edge GP Ltd., Hilliyon Holdings, Berko Capital, and Dr. Tomer Berkovitz.
- No other transactions in Ordinary Shares were effected by the Reporting Persons during the last 60 days.
Financial Impact
Sale of 192,541 shares at $7.70 per share, gross proceeds of approximately $1.48 million. The stake decreased from an undisclosed prior level to 5,318,023 shares (6.2%).
Risk Factors
- Further sales by the activist group could pressure the stock.
- The reduction in stake may indicate waning activist pressure or a shift in strategy.
- The filing does not disclose the reason for the sale, leaving intent unclear.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001178913-26-005168 |
| Document: 0001178913-26-005168-index.html | 0001178913-26-005168 |
| Document: 0001178913-26-005168.txt | 0001178913-26-005168 |
Track record
47 reports on SOPH
5 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +64.11% at T+60 after the Jun 4, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry $7.45 Now $7.45 −0.00% settles Nov 25
- Nov 16, 2026today 144 Neutral 2/10 Entry $7.44 Now $7.45 +0.13% settles Nov 24
- Nov 12, 20265d ago Insider Cluster Mixed 4/10 Entry $8.21 Now $7.45 −9.26% settles Nov 20
- Nov 12, 20265d ago SC 13D/A Neutral 3/10 Viewing Entry $7.86 Now $7.45 −5.22% settles Nov 19
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $7.86 Now $7.45 −5.22% due Nov 17
- Nov 9, 20268d ago Insider Cluster Bullish 4/10 Entry $7.86 Now $7.45 −5.22% due Nov 17
- Nov 3, 202614d ago 6-K Neutral 5/10 No price data
- Nov 3, 202614d ago Press Release Neutral 5/10 Entry $6.91 to $7.86 Now $7.45 +7.81% ▲ +13.75% +14.34% vs SPY
- Oct 14, 20264w ago Insider Cluster Neutral 2/10 Entry $7.29 to $7.05 Now $7.45 +2.19% ▼ −3.29% −2.28% vs SPY
- Oct 5, 20266w ago 144 Neutral 2/10 Entry $7.38 to $7.09 Now $7.45 +0.95% ▼ −3.93% −3.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers